FXH:ARCA-First Trust Health Care AlphaDEX (USD)

ETF | Health | NYSE Arca

Last Closing

USD 105.59

Change

0.00 (0.00)%

Market Cap

USD 0.92B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant(R) Health Care Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is a modified equal-dollar weighted index designed by NYSE to objectively identify and select stocks from the Russell 1000(R) Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX(R) selection methodology.

Inception Date: 08/05/2007

Primary Benchmark: StrataQuant Health Care TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.61%

Management Expense Ratio: 0.63 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-25 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV Health Care Select Sector SPDR.. 0.13 %

+0.28 (+0.20%)

USD 36.67B
FHLC Fidelity® MSCI Health Care In.. 0.08 %

+0.19 (+0.29%)

USD 2.62B
XHE SPDR® S&P Health Care Equipme.. 0.35 %

+0.72 (+0.80%)

USD 0.21B
IDNA iShares Genomics Immunology an.. 0.00 %

+0.13 (+0.57%)

USD 0.12B
SBIO ALPS Medical Breakthroughs ETF 0.50 %

+0.64 (+1.90%)

USD 0.11B
XHS SPDR® S&P Health Care Service.. 0.35 %

+0.68 (+0.75%)

USD 0.07B
HTEC Robo Global® Healthcare Techn.. 0.00 %

+0.16 (+0.55%)

USD 0.05B
BBP Virtus LifeSci Biotech Product.. 0.79 %

+0.69 (+1.13%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica.. 0.79 %

+0.42 (+1.71%)

USD 0.01B
IHF iShares U.S. Healthcare Provid.. 0.43 %

+0.19 (+0.39%)

N/A

ETFs Containing FXH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.97% 24% F 45% F
Dividend Return 0.33% 25% F 3% F
Total Return 2.30% 24% F 33% F
Trailing 12 Months  
Capital Gain 1.82% 43% F 46% F
Dividend Return 0.33% 25% F 3% F
Total Return 2.15% 38% F 34% F
Trailing 5 Years  
Capital Gain 25.02% 57% F 63% D
Dividend Return 0.96% 32% F 3% F
Total Return 25.97% 52% F 53% F
Average Annual (5 Year Horizon)  
Capital Gain 5.71% 52% F 53% F
Dividend Return 5.83% 52% F 46% F
Total Return 0.13% 32% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 16.40% 62% D 63% D
Risk Adjusted Return 35.59% 62% D 50% F
Market Capitalization 0.92B 80% B- 58% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.